Novel functional micropeptides, such as MP-31, might serve as potential targets for GBM treatments

The metabolic role of micropeptides generated from untranslated regions remains unclear. Here we describe MP31, a micropeptide encoded by the upstream open reading frame (uORF) of phosphatase and tensin homolog (PTEN) acting as a "circuit breaker" that limits lactate-pyruvate conversion in mitochondria by competing with mitochondrial lactate dehydrogenase (mLDH) for nicotinamide adenine dinucleotide (NAD+). Knocking out the MP31 homolog in mice enhanced global lactate metabolism, manifesting as accelerated oxidative phosphorylation (OXPHOS) and increased lactate consumption and production. Conditional knockout (cKO) of MP31 homolog in mouse astrocytes initiated gliomagenesis and shortened the overall survival of the animals, establishing a tumor-suppressing role for MP31. Recombinant MP31 administered intraperitoneally penetrated the blood-brain barrier and inhibited mice GBM xenografts without neurological toxicity, suggesting the clinical implication and application of this micropeptide. Our findings reveal a novel mode of MP31-orchestrated lactate metabolism reprogramming in glioblastoma.


Huang N, Li F, Zhang M, et al. An upstream open reading frame in phosphatase and tensin homolog encodes a circuit breaker of lactate metabolism. Cell Metabolism. 2021;33(1):128-144.e9.


Updates coming soon.

Related Products

Catalog# Product Standard Size Price
037-79 MP31 / Micropeptide-31 (1-14) –Amide (Mouse) 200 µg $195
037-80 MP31 / Micropeptide-31 (18-35) (Mouse) 100 µg $145
037-76 MP31 / Micropeptide-31 (Human) 100 µg $275
037-78 MP31 / Micropeptide-31 (Mouse) 100 µg $295